PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP1R (rs6923761) and other pathways that influence how efficiently semaglutide lowers your blood sugar and affects your hypoglycemia risk profile
Healthcare professionals should assess retinopathy status before initiating GLP-1 receptor agonists and consider ophthalmology referral for patients with moderate to severe non-proliferative or proliferative diabetic retinopathy, particularly if rapid glucose improvements are anticipated
Nausea, occasional vomiting, and digestive changes are common
Read our story on semaglutide at the link below, and subscribe to The Juggernaut for all of the South Asian news you need to know
Key signs include: Persistent, severe abdominal pain that often radiates to the back Nausea and vomiting, which may accompany or follow the pain Abdominal tenderness, sometimes with a swollen or distended abdomen Fever and an elevated heart rate, which indicate inflammation or infection Risk Reduction Strategies For those using Mounjaro, taking proactive steps can help minimise risks: Before starting Mounjaro, discuss your medical history, particularly if you have a history of pancreatitis, gallstones, or other pancreatic conditions with a healthcare professional or book a consultation with us to discuss your suitability
Results from the PIONEER PLUS and OASIS trials showed that Rybelsus, an oral version of semaglutide, is effective for treating type 2 diabetes and overweight or obesity at high doses